In a nutshell This study aimed to investigate the impact of time to response to treatment on the outcomes of patients with accelerated-phase chronic myeloid leukemia. This study concluded that an early response to treatment is strongly associated with long-term survival in these patients. Some background Tyrosine...
Read MoreCurrent disease phase-Advanced phase-Accelerated phase Posts on Medivizor
The safety and effectiveness of nilotinib in the treatment of unresponsive CML
In a nutshell This study examined the safety and effectiveness of using nilotinib (Tasigna) in patients with chronic myeloid leukemia (CML) unresponsive to other treatment. The study concluded that nilotinib is safe and effective in the treatment of CML unresponsive to imatinib (Gleevec). Some background Chronic myeloid leukemia is a cancer of the...
Read More